Edwards Lifesciences Corp. said that its board has authorized a program to repurchase up to an additional $750 million worth of the company’s stock, Dow Jones reported. The company has a market capitalization value of $7.6 billion, according to FactSet. Separately Tuesday, the company said chief financial officer Thomas M. Abate will retire this year; he turns 60 in August. Edwards is the biggest maker of aortic heart valves implanted with a catheter.
Edwards Lifesciences to buy back shares
You've reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week